Life ScienceCompany
Who owns Sublimity Therapeutics?
Sublimity Therapeutics is publicly traded.
Sublimity Therapeutics is publicly traded.
The Invent Centre, Dublin City University,
Dublin,
9
Ireland,
+353 1 700 7511
www.sigmoidpharma.com
| Status | Dates | Investor(s) | |
|---|---|---|---|
| Investment | Exit | ||
| Exited | 2018-05-22 | 2021-04-19 | HBM Partners |
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.